The use of inhibitors of angiogenesis in patients with inoperable locally advanced or metastatic renal cell cancer: guideline recommendations

GUIDELINE TITLE
The use of inhibitors of angiogenesis in patients with inoperable locally advanced or metastatic renal cell cancer: guideline recommendations.

BIBLIOGRAPHIC SOURCE(S)
Hotte S, Waldron T, Bjarnason G, Jewett M, MacKenzie M, Segal R, Winquist E, Genitourinary Cancer Disease Site Group. The use of inhibitors of angiogenesis in patients with inoperable locally advanced or metastatic renal cell cancer: guideline recommendations. Toronto (ON): Cancer Care Ontario (CCO); 2009 Apr 30. 45 p. (Evidence-based series; no. 3-8-4). [63 references]

GUIDELINE STATUS
This is the current release of the guideline.

The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site for details on any new evidence that has emerged and implications to the guidelines.
http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=43557

abrir aquí para acceder al documento NGC AHRQ completo:
http://www.guideline.gov/summary/summary.aspx?view_id=1&doc_id=14707